eli lilly and company tirzepatide FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems FDA approves Zepbound (tirzepatide) as
Pay in 4 interest-free payments of $5.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 18 - Nov 23

:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120470-2b143445f1924b8a9050fb3a639779df.jpg)











00188-2/asset/060af149-96d8-44a2-9e4d-318ecc8ae69e/main.assets/gr1_lrg.jpg)







